Shining a light in the black box of orphan drug pricing

BACKGROUND: The pricing mechanism of orphan drugs appears arbitrary and has been referred to as a “black box”. Therefore, the aim of this study is to investigate how drug- and disease-specific variables relate to orphan drug prices. Additionally, we aim to explore if certain country-specific pricing...

Descripción completa

Detalles Bibliográficos
Autores principales: Picavet, Eline, Morel, Thomas, Cassiman, David, Simoens, Steven
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4018963/
https://www.ncbi.nlm.nih.gov/pubmed/24767472
http://dx.doi.org/10.1186/1750-1172-9-62

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4018963/
https://www.ncbi.nlm.nih.gov/pubmed/24767472
http://dx.doi.org/10.1186/1750-1172-9-62

Ejemplares similares